Featured Quizzes
User Quizzes
Create Quiz
Data and Charts
Word Search
Badges and Games
About JetPunk
Message Board
Dark Mode
Finals drugs list - Statistics
General Stats
- This quiz has been taken 18 times
- The average score is 25 of 377
Answer Stats
| Hint | Answer | % Correct |
|---|---|---|
| Strong opioid analgesic | Fentanyl | 54%
|
| Antiplatelet | Aspirin | 38%
|
| Non-steroidal anti-inflammatory drug (NSAIDs) | Ibuprofen | 38%
|
| Strong opioid analgesic | Morphine | 38%
|
| Benzodiazepine (BDZs) | Diazepam | 31%
|
| Selective serotonin reuptake inhibitor (SSRIs) | Fluoxetine | 31%
|
| Antipsychotics - classical (1st generation) | Haloperidol | 31%
|
| Proton-pump inhibitor | Omeprazole | 31%
|
| Weak analgesic/antipyretic | Paracetamol | 31%
|
| Selective serotonin reuptake inhibitor (SSRIs) | Sertraline | 31%
|
| Neuropathic pain drug | Tricyclic antidepressant (TCAs) | Amitriptyline | 23%
|
| Penicillin (beta-lactam) antibiotic | Amoxicillin | 23%
|
| Opioid anti-motility agent | Weak opioid analgesic | Codeine | 23%
|
| H2-receptor antagonist | Famotidine | 23%
|
| Corticosteroid - IV | Corticosteroids for inflammatory diseases | Hydrocortisone | 23%
|
| NMDA receptor blockade | Ketamine | 23%
|
| Osmotic laxative | Lactulose | 23%
|
| Benzodiazepine (BDZs) | Lorazepam | 23%
|
| Osmotic laxative | Macrogol | 23%
|
| Opioid antagonist | Naloxone | 23%
|
| Antipsychotics - atypical (2nd generation) | Olanzapine | 23%
|
| Mixed agonist opioid analgesic | Tramadol | 23%
|
| Atypical antidepressants | Venlafaxine | 23%
|
| Benzodiazepine (BDZs) - BDZ-like | Zolpidem | 23%
|
| Paracetamol antidote | Acetylcysteine | 15%
|
| Adenosine receptor activator slowing conduction through AV node | Adenosine | 15%
|
| Sympathomimetic | Adrenaline | 15%
|
| Antacids | Aluminium and magnesium hydroxide/calcium carbonate | 15%
|
| Class III anti-arrhythmic - potassium channel blocker | Amiodarone | 15%
|
| HMG-CoA Reductase inhibitor | Atorvastatin | 15%
|
| Antimuscarinic | Atropine | 15%
|
| Macrolide antibiotic | Azithromycin | 15%
|
| Beta adrenergic receptor antagonist (beta blocker) | Bisoprolol | 15%
|
| Mixed agonist opioid analgesic | Opioid addiction management | Buprenorphine | 15%
|
| Dopa-decarboxylase inhibitor | Carbidopa | 15%
|
| COX-2 selective NSAIDs | Celecoxib | 15%
|
| Anti-histamine (H1 receptor blockade) | Cetirizine | 15%
|
| H2-receptor antagonist | Cimetidine | 15%
|
| Selective serotonin reuptake inhibitor (SSRIs) | Citalopram | 15%
|
| Lincosamide antibiotic | Clindamycin | 15%
|
| Alpha-2 adrenergic agonist | Clonidine | 15%
|
| Anticoagulant - low molecular weight heparin | Dalteparin | 15%
|
| Non-steroidal anti-inflammatory drug (NSAIDs) | Diclofenac | 15%
|
| Weak opioid analgesic | Dihydrocodeine | 15%
|
| Faecal softener | Docusate | 15%
|
| Anticoagulant - low molecular weight heparin | Enoxaparin | 15%
|
| Loop diuretic | Furosemide | 15%
|
| Aminoglycoside antibiotic | Gentamicin | 15%
|
| Anti-epilepsy drug | Lamotrigine | 15%
|
| Proton-pump inhibitor | Lansoprazole | 15%
|
| Dopamine precursor | Levodopa | 15%
|
| Class I anti-arrhythmic - sodium channel blocker (class Ib) | Local anaesthetic | Lidocaine | 15%
|
| Angiotensin-converting enzyme inhibitor | Lisinopril | 15%
|
| Mood stabiliser | Lithium carbonate | 15%
|
| Opioid anti-motility agent | Loperamide | 15%
|
| Anti-histamine (H1 receptor blockade) | Loratadine | 15%
|
| Angiotensin II receptor blocker | Losartan | 15%
|
| Non-steroidal anti-inflammatory drug (NSAIDs) | Naproxen | 15%
|
| Sympathomimetic | Noradrenaline | 15%
|
| Tricyclic antidepressant (TCAs) | Nortriptyline | 15%
|
| 5-HT3-receptor antagonist | Ondansetron | 15%
|
| Strong opioid analgesic | Oxycodone | 15%
|
| Pancreatic Enzymes | Pancreatin | 15%
|
| Corticosteroid - oral | Corticosteroids for inflammatory diseases | Prednisolone | 15%
|
| Neuropathic pain drug | Pregabalin | 15%
|
| General anaesthetic | Propofol | 15%
|
| Beta adrenergic receptor antagonist (beta-1 and beta-2 selective) | Propranolol | 15%
|
| Antipsychotics - atypical (2nd generation) | Quetiapine | 15%
|
| Angiotensin-converting enzyme inhibitor | Ramipril | 15%
|
| Anticoagulant - direct factor Xa inhibitor | Rivaroxaban | 15%
|
| Cholinesterase inhibitor | Rivastigmine | 15%
|
| Beta-2 adrenergic agonist - short-acting | Salbutamol | 15%
|
| Stimulant laxative | Senna | 15%
|
| Potassium sparing diuretic | Spironolactone | 15%
|
| Tetracycline antibiotic | Tetracycline | 15%
|
| Catechol-O-methyl transferase inhibitor (COMT) | Tolcapone | 15%
|
| Glycopeptide antibiotic | Vancomycin | 15%
|
| Anticoagulant - coumarin | Warfarin | 15%
|
| Non-benzodiazepine hypnotic | Zopiclone | 15%
|
| Substance abuse treatment agent (for alcohol rehabilitation) | Acamprosate | 8%
|
| Carbonic anhydrase inhibitor | Acetazolamide | 8%
|
| Xanthine oxidase inhibitor | Allopurinol | 8%
|
| Thrombolytic/fibrinolytic | Alteplase | 8%
|
| Potassium sparing diuretic | Amiloride | 8%
|
| Methylxanthine | Aminophylline | 8%
|
| Calcium channel antagonist (CCB) | Amlodipine | 8%
|
| Anticoagulant - direct factor Xa inhibitor | Apixaban | 8%
|
| Faecal softener | Arachis oil | 8%
|
| Beta adrenergic receptor antagonist (beta blocker) | Atenolol | 8%
|
| Corticosteroid - inhaled | Beclomethasone | 8%
|
| Thiazide | Bendroflumethiazide | 8%
|
| Dopa-decarboxylase inhibitor | Benserazide | 8%
|
| Penicillin (beta-lactam) antibiotic | Benzylpenicillin | 8%
|
| Stimulant laxative | Bisacodyl | 8%
|
| Corticosteroid - oral | Budesonide | 8%
|
| Atypical antidepressants | Buproprion | 8%
|
| Angiotensin II receptor blocker | Candesartan | 8%
|
| Angiotensin-converting enzyme inhibitor | Captopril | 8%
|
| Anti-epilepsy drug | Carbamazepine | 8%
|
| Mucolytic | Carbocisteine | 8%
|
| Cephalosporin (beta-lactam) antibiotic | Ceftriaxone | 8%
|
| Cephalosporin (beta-lactam) antibiotic | Cefuroxime | 8%
|
| Benzodiazepine (for alcohol withdrawal) | Chlordiazepoxide | 8%
|
| Thiazide | Chlorthalidone | 8%
|
| Fluoroquinolone antibiotic | Ciprofloxacin | 8%
|
| Antipsychotics - atypical (2nd generation) | Clozapine | 8%
|
| Penicillin (beta-lactam) antibiotic | Co-amoxiclav | 8%
|
| Anti-gout agent | Colchicine | 8%
|
| Vitamin D deficiency drugs | Colecalciferol (vitamin D3) | 8%
|
| Anti-folate antibiotic | Co-trimoxazole | 8%
|
| H1-receptor antagonist | Cyclizine | 8%
|
| HIV viral protease inhibitors | Darunavir | 8%
|
| Strong opioid analgesic | Diamorphine | 8%
|
| Calcium channel antagonist (non-dihydropyridine) | Class IV anti-arrhythmic - calcium channel blocker | Diltiazem | 8%
|
| Sympathomimetic | Dobutamine | 8%
|
| D2-receptor antagonist | Domperidone | 8%
|
| Cholinesterase inhibitor | Donepezil | 8%
|
| Alpha-1 adrenergic antagonist | Doxazosin | 8%
|
| Tetracycline antibiotic | Doxycycline | 8%
|
| Atypical antidepressants | Duloxetine | 8%
|
| Catechol-O-methyl transferase inhibitor (COMT) | Entacapone | 8%
|
| Potassium sparing diuretic | Epleronone | 8%
|
| Macrolide antibiotic | Erythromycin | 8%
|
| Anti-epilepsy drug | Ethosuximide | 8%
|
| COX-2 selective NSAIDs | Etoricoxib | 8%
|
| Xanthine oxidase inhibitor | Febuxostat | 8%
|
| Penicillin (beta-lactam) antibiotic | Flucloxacillin | 8%
|
| Corticosteroid - inhaled | Fluticasone | 8%
|
| Beta-2 adrenergic agonist - long-acting | Formoterol | 8%
|
| Neuropathic pain drug | Gabapentin | 8%
|
| Cholinesterase inhibitor | Galantamine | 8%
|
| Nitrate | Glyceryl trinitrate | 8%
|
| Thiazide | Hydrochlorothiazide | 8%
|
| Thiazide | Indapamide | 8%
|
| Anti-muscarinic/anti-cholinergic - short-acting | Ipratropium | 8%
|
| Nitrate | Isosorbide mononitrate | 8%
|
| Bulk laxative | Isphagula husk | 8%
|
| Selective I(f) current inhibitor | Ivabradine | 8%
|
| Essential nutrient altering Na, K and Ca ion balance via ion channels | IV Magnesium sulfate | 8%
|
| T4 thyroid hormone | Levothyroxine sodium | 8%
|
| Osmotic laxative | Magnesium sulphate | 8%
|
| Anti-helmintics - worms | Mebendazole | 8%
|
| NMDA receptor antagonist | Memantine | 8%
|
| Carbapenem (beta-lactam) antibiotic | Meropenem | 8%
|
| Oral biguanide - increases insulin sensitivity | Metformin | 8%
|
| Opioid addiction management | Methadone | 8%
|
| Bulk laxative | Methylcellulose | 8%
|
| D2-receptor antagonist | Metoclopramide | 8%
|
| Beta adrenergic receptor antagonist (beta-1 selective) | Metoprolol | 8%
|
| Nitroimidazole antibiotic (anti-anaerobe agent) | Metronidazole | 8%
|
| Benzodiazepine (BDZs) | Midazolam | 8%
|
| Beta-3 agonist | Mirabegron | 8%
|
| Atypical antidepressants | Mirtazapine | 8%
|
| Leukotriene antagonist | Montelukast | 8%
|
| Opioid antagonist | Naltrexone | 8%
|
| Reversal of neuromuscular block - peripheral acetylcholinesterase inhibitor | Neostigmine | 8%
|
| Calcium channel antagonist (dihydropyridine subclass) | Nifedipine | 8%
|
| Nitrofuran antibiotic | Nitrofurantoin | 8%
|
| Neuraminidase inhibitor (prevents viral infectivity) - influenza | Oseltamivir | 8%
|
| Urinary anti-spasmodic (anti-muscarinic) | Oxybutynin | 8%
|
| Labour augmentation | Oxytocin | 8%
|
| Selective serotonin reuptake inhibitor (SSRIs) | Paroxetine | 8%
|
| Barbiturate | Phenobarbitone | 8%
|
| Penicillin (beta-lactam) antibiotic | Phenoxymethylpenicillin | 8%
|
| Anti-epilepsy drug | Phenytoin | 8%
|
| Stimulant laxative | Picosulfate | 8%
|
| Reversal of neuromuscular block - peripheral acetylcholinesterase inhibitor | Pyridostigmine | 8%
|
| Monoamine oxidase B inhibitor (MAOIs) | Rasagiline | 8%
|
| Atypical antidepressants | Reboxetine | 8%
|
| Muscle relaxant - opioid | Strong opioid analgesic | Synthetic opioid analgesic used in labour | Remifentanil | 8%
|
| Antipsychotics - atypical (2nd generation) | Risperidone | 8%
|
| HIV viral protease inhibitors | Ritonavir | 8%
|
| Neuromuscular blockers (non-depolarising) - paralytic | Rocuronium | 8%
|
| Neprilysin inhibitor (used in combination with an ARB) | Sacubitril | 8%
|
| Beta-2 adrenergic agonist - long-acting | Salmeterol | 8%
|
| Monoamine oxidase B inhibitor (MAOIs) | Selegiline | 8%
|
| HMG-CoA Reductase inhibitor | Simvastatin | 8%
|
| Anti-epilepsy drug | Sodium valproate | 8%
|
| Thrombolytic/fibrinolytic | Streptokinase | 8%
|
| Reversal of neuromuscular block - oligosaccharide | Sugammadex | 8%
|
| Migraine onset - serotonin receptor agonist | Sumatriptan | 8%
|
| Neuromuscular blockers (depolarising) - paralytic | Suxamethonium | 8%
|
| Alpha-1 blocker | Tamsulosin | 8%
|
| Nucleoside reverse transcriptase inhibitors (NRTIs) - HIV | Tenofovir | 8%
|
| Beta-2 adrenergic agonist - short-acting | Terbutaline | 8%
|
| Methylxanthine | Theophylline | 8%
|
| Anticoagulant - low molecular weight heparin | Tinzaparin | 8%
|
| Anti-muscarinic/anti-cholinergic - long-acting | Tiotropium | 8%
|
| Anti-folate antibiotic | Trimethoprim | 8%
|
| Anticoagulant - standard heparin | Unfractionated heparin | 8%
|
| Thrombolytic/fibrinolytic | Urokinase | 8%
|
| Angiotensin II receptor blocker | Valsartan | 8%
|
| Class IV anti-arrhythmic - calcium channel blocker | Verapamil | 8%
|
| Leukotriene antagonist | Zafirlukast | 8%
|
| Thiopurine anti-proliferative - RA/Crohn's | 6-mercaptopurine | 0%
|
| Nucleoside reverse transcriptase inhibitors (NRTIs) - HIV | Abacavir | 0%
|
| DNA polymerase inhibitor (blockade virus replication) - HSV | Aciclovir | 0%
|
| Retinoids | Acitretin | 0%
|
| Anti-muscarinic/anti-cholinergic - long-acting | Aclidinium | 0%
|
| Cytokine modulators (TNF-alpha blockade) - RA/Crohn's | Adalimumab | 0%
|
| Atypical antidepressants | Agomelatine | 0%
|
| Bisphosphonate | Alendronate | 0%
|
| Muscle relaxant - opioid | Alfentanil | 0%
|
| Direct renin inhibitor | Aliskiren | 0%
|
| Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins | Alogliptin | 0%
|
| Antipsychotics - atypical (2nd generation) | Amisulpride | 0%
|
| HIV viral protease inhibitors | Atazanavir | 0%
|
| Class II anti-arrhythmic - beta-adrenergic antagonist/beta blocker | Atenolol, bisoprolol, metoprolol, sotalol | 0%
|
| Neuromuscular blockers (non-depolarising) - paralytic | Atracurium besilate | 0%
|
| Phosphodiesterase-5 (PDE5) inhibitor - short-acting | Avanafil | 0%
|
| Thiopurine anti-proliferative - RA/Crohn's | Azathioprine | 0%
|
| HIV integrase strand transfer inhibitors | Bictegravir | 0%
|
| Dopamine receptor agonist | Bromocriptine | 0%
|
| Local anaesthetic | Bupivacaine | 0%
|
| Atypical antidepressants | Buspirone | 0%
|
| Dopamine receptor agonist | Cabergoline | 0%
|
| HIV integrase strand transfer inhibitors | Cabotegravir | 0%
|
| Therapeutic hormones - osteoporosis | Calcitonin | 0%
|
| Vitamin D deficiency drugs | Calcitriol (1,25-dihydroxyvitamin D) | 0%
|
| SGLT-2 inhibitor | Canagliflozin | 0%
|
| Anti-thyroid drug - hyperthyroidism | Carbimazole | 0%
|
| Anti-histamine (H1 receptor blockade) | Chlorphenamine | 0%
|
| Antipsychotics - classical (1st generation) | Chlorpromazine | 0%
|
| Non-benzodiazepine hypnotic (for alcohol withdrawal) | Clomethiazole | 0%
|
| Antiplatelet (purinergic receptor blocker) | Clopidogrel | 0%
|
| Triazole anti-fungal agent - candida | Clotrimazole | 0%
|
| Classical alkylating agents - malignancy | Cyclophosphamide | 0%
|
| Calcineurin inhibitor | Cyclosporin | 0%
|
| Anti-pyrimidines - malignancy | Cytarabine | 0%
|
| Anticoagulant - direct thrombin inhibitor | Dabigatran | 0%
|
| SGLT-2 inhibitor | Dapagliflozin | 0%
|
| Monoclonal antibody for osteoporosis | Denosumab | 0%
|
| Vasopressin analogue - diabetes insipidus | Desmopressin | 0%
|
| Oral mini-pill contraceptive | Desogestrel | 0%
|
| Corticosteroids for inflammatory diseases | Dexamethasone | 0%
|
| Muscle relaxant - alpha-2 agonist | Dexmedetomidine | 0%
|
| Cardiac glycoside | Digoxin | 0%
|
| Labour induction | Dinoprostone | 0%
|
| Class I anti-arrhythmic - sodium channel blocker (class Ia) | Disopyramide | 0%
|
| Taxanes - malignancy | Docetaxel | 0%
|
| HIV integrase strand transfer inhibitors | Dolutegravir | 0%
|
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) - HIV | Doravirine | 0%
|
| Mucolytic | Dornase alfa | 0%
|
| Tricyclic antidepressant (TCAs) | Dosulepin | 0%
|
| Class III anti-arrhythmic - potassium channel blocker | Dronedarone | 0%
|
| Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue | Dulaglutide | 0%
|
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) - HIV | Efavirenz | 0%
|
| SGLT-2 inhibitor | Empagliflozin | 0%
|
| Nucleoside reverse transcriptase inhibitors (NRTIs) - HIV | Emtricitabine | 0%
|
| SGLT-2 inhibitor | Ertugliflozin | 0%
|
| Cytokine modulators (TNF-alpha blockade) - RA/Crohn's | Etanercept | 0%
|
| Anti-TB drug (inhibits mycobacterial cell wall synthesis) | Ethambutol | 0%
|
| Oral combined contraceptive pill | Ethinylestradiol with desogestrel | 0%
|
| Implant contraceptive | Etonorgestrel | 0%
|
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) - HIV | Etravirine | 0%
|
| Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue | Exenatide | 0%
|
| PPAR-alpha activator | Fenofibrate | 0%
|
| Oral iron compound | Ferrous sulphate | 0%
|
| Synthetic G-CSF - neutropenia | Filgrastim | 0%
|
| Anti-androgens | Finasteride | 0%
|
| Class I anti-arrhythmic - sodium channel blocker (class Ic) | Flecainide | 0%
|
| Triazole anti-fungal agent - candida | Fluconazole | 0%
|
| Benzodiazepine antagonist | Flumazenil | 0%
|
| Anti-pyrimidines - malignancy | Fluorouracil | 0%
|
| Essential nutrient in normal pregnancy | Folic acid | 0%
|
| DNA polymerase inhibitor (blockade virus replication) - HSV | Ganciclovir | 0%
|
| Sulphonylurea - stimulates pancreatic insulin secretion | Gliclazide | 0%
|
| Anti-muscarinic/anti-cholinergic - long-acting | Glycopyrronium | 0%
|
| Luteinising hormone releasing hormone (LHRH) receptor agonist - prostate cancer | Goserelin | 0%
|
| Vitamin B12 replacement | Hydroxocabalamin | 0%
|
| NSAID for gout | Indomethacin | 0%
|
| Cytokine modulators (TNF-alpha blockade) - RA/Crohn's | Infliximab | 0%
|
| Glucose reducing hormone - short acting | Insulin aspart | 0%
|
| Glucose reducing hormone - very long acting | Insulin degludec | 0%
|
| Glucose reducing hormone - long acting | Insulin glargine | 0%
|
| Glucose reducing hormone - medium acting | Insulin isophane | 0%
|
| Glucose reducing hormone - long acting | Insulin levemir | 0%
|
| Glucose reducing hormone - short acting | Insulin lispro | 0%
|
| Glucose reducing hormone - very long acting | Insulin toujeo | 0%
|
| Therapeutic cytokines (activates anti-viral response) - Hep B and C | Interferon alpha | 0%
|
| Angiotensin II receptor blocker | Irbesartan | 0%
|
| General anaesthetic | Isoflurane | 0%
|
| Anti-TB drug (inhibits mycobacterial cell wall synthesis) | Isoniazid | 0%
|
| Sympathomimetic | Isoprenaline | 0%
|
| Retinoids | Isotretinoin | 0%
|
| Hypocalcaemia drugs | IV Calcium gluconate, vitamin D, PTH | 0%
|
| Beta adrenergic receptor antagonist (beta-1, beta-2 and alpha-1 selective) | Labetolol | 0%
|
| Anti-metabolite anti-proliferative - RA | Leflunomide | 0%
|
| Immunomodulator - myeloma | Lenolidamide | 0%
|
| Anti-epilepsy drug | Levetiracetam | 0%
|
| Local anaesthetic | Levobupivacaine | 0%
|
| Oral mini-pill contraceptive | Levonorgestrel | 0%
|
| Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins | Linagliptin | 0%
|
| T3 thyroid hormone | Liothyronine sodium | 0%
|
| Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue | Liraglutide | 0%
|
| Osmotic laxative | Magnesium hydroxide | 0%
|
| Osmotic diuretic | Mannitol | 0%
|
| Injectable contraceptive | Medroxyprogesterone | 0%
|
| NSAID - dysmenorrhoea | Mefenamic acid | 0%
|
| Anti-purines - malignancy | Mercaptopurine | 0%
|
| Aminosalicylate | Mesalazine | 0%
|
| Sympathomimetic | Metaraminol | 0%
|
| Anti-folate anti-proliferative - RA | Methotrexate | 0%
|
| Inhaled analgesic | Methoxyflurane | 0%
|
| Anti-progestogen/prostaglandin - medical termination | Mifepristone with misoprostol | 0%
|
| Reversible inhibitor of monoamine oxidase type A (RIMA) | Moclobemide | 0%
|
| Inosine monophosphate dehydrogenase inhibitor - transplants | Mycophenolate | 0%
|
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) - HIV | Nevirapine | 0%
|
| Inhaled analgesic | Nitrous oxide and oxygen mix | 0%
|
| Anti-neoplastic monoclonal antibodies for melanoma | Nivolumab | 0%
|
| H2-receptor antagonist | Nizatidine | 0%
|
| Hormone replacement therapy | Oestrogen and medroxyprogesterone or noresthisterone | 0%
|
| Lipase inhibitor - inhibits uptake of dietary fat | Orlistat | 0%
|
| Anticholinergic | Orphenadrine | 0%
|
| Taxanes - malignancy | Paclitaxel | 0%
|
| Bisphosphonate | Pamidronate | 0%
|
| Barbiturate | Pentobarbitone | 0%
|
| Angiotensin-converting enzyme inhibitor | Perindopril | 0%
|
| Pyrethrines (anti-infestation) - scabies | Permethrin | 0%
|
| Strong opioid analgesic | Synthetic opioid analgesic used in labour | Pethidine | 0%
|
| Thiazolidinediones - increases insulin sensitivity in muscle and adipose tissue | Pioglitazone | 0%
|
| Penicillin (beta-lactam) antibiotic | Piperacillin tazobactam (tazocin) | 0%
|
| Dopaminergic | Pramipexole | 0%
|
| Antiplatelet (purinergic receptor blocker) | Prasugrel | 0%
|
| Barbiturate | Primidone | 0%
|
| Anticholinergic | Procyclidine | 0%
|
| Class I anti-arrhythmic - sodium channel blocker (class Ic) | Propafenone | 0%
|
| Anti-thyroid drug - hyperthyroidism | Propylthiouracil | 0%
|
| Anti-TB drug | Pyrazinamide | 0%
|
| HIV integrase strand transfer inhibitors | Raltegravir | 0%
|
| Nucleoside analogue (disrupts viral RNA synthesis) - Hep C and RSV | Ribavirin | 0%
|
| Anti-TB drug (inhibits mycobacterial RNA synthesis) | Rifampicin | 0%
|
| Bisphosphonate | Risedronate | 0%
|
| Anti-neoplastic monoclonal antibodies for lymphoma | Rituximab | 0%
|
| Dopaminergic - synthetic agonist | Ropinirole | 0%
|
| HMG-CoA Reductase inhibitor | Rosuvastatin | 0%
|
| Dopaminergic - synthetic agonist | Rotigotine | 0%
|
| Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins | Saxagliptin | 0%
|
| Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue | Semaglutide | 0%
|
| General anaesthetic | Sevoflurane | 0%
|
| Phosphodiesterase-5 (PDE5) inhibitor - short-acting | Sildenafil | 0%
|
| Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins | Sitagliptin | 0%
|
| Antacid + alginates | Sodium alginate with sodium bicarbonate | 0%
|
| Urinary anti-spasmodic (anti-muscarinic) | Solifenacin | 0%
|
| Class III anti-arrhythmic - potassium channel blocker | Sotalol | 0%
|
| Anti-folate antibiotic | Sulfamethoxazole | 0%
|
| Aminosalicylate | Sulfasalazine | 0%
|
| Calcineurin inhibitor | Tacrolimus | 0%
|
| Phosphodiesterase-5 (PDE5) inhibitor - long-acting | Tadalafil | 0%
|
| Selective estrogen receptor modulator (SERM) - breast cancer | Tamoxifen | 0%
|
| Muscle relaxant - BDZ | Temazepam | 0%
|
| Hypocalcaemia drugs | Teriparatide | 0%
|
| Dopamine-depleting drugs | Tetrabenazine | 0%
|
| Anti-purines - malignancy | Thioguanine | 0%
|
| Antiplatelet (purinergic receptor blocker) | Ticagrelor | 0%
|
| Aminoglycoside antibiotic | Tobramycin | 0%
|
| Urinary anti-spasmodic (anti-muscarinic) | Tolterodine | 0%
|
| Anti-epilepsy drug | Migraine prophylaxis - anticonvulsant | Topiramate | 0%
|
| Anti-fibrinolytic - menorrhagic | Tranexamic acid | 0%
|
| Anti-neoplastic monoclonal antibodies for early breast cancer | Trastuzumab | 0%
|
| Anticholinergic | Trihexphenidyl | 0%
|
| Progesterone receptor modulator - emergency contraception | Ulipristal | 0%
|
| Neuromuscular blockers (non-depolarising) - paralytic | Vecuronium | 0%
|
| Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins | Vildagliptin | 0%
|
| Essential nutrient in normal pregnancy | Vitamin D | 0%
|
| Nucleoside reverse transcriptase inhibitors (NRTIs) - HIV | Zidovudine | 0%
|
No matching quizzes found
Score Distribution
Percent of People with Each Score
Percentile by Number Answered
Your Score History
You have not taken this quiz
New and Popular